PANCREATIC HORMONES-II Dr.Mohammed Sharique Ahmed Quadri Assistant professor Almaarefa College 1.
Pancreatic Hormones & Antidiabetic Drugs
-
Upload
saddamix-al-omari -
Category
Documents
-
view
115 -
download
2
Transcript of Pancreatic Hormones & Antidiabetic Drugs
![Page 1: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/1.jpg)
Pancreatic Hormones & Antidiabetic Drugs
Dr. Meera Ababneh, Pharm.D, PhD
![Page 2: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/2.jpg)
PancreasType of cells Approximate Percent of
Islet MassHormones secreted
Alpha (A) cell 20 Glucagon
Beta (B) cell 75 Insulin, C-peptide, proinsulin, amylin
Delta (D) cell 3-5 Somatostatin
G cell 1 Gastrin
F cell (PP cell) 1 Pancreatic polypeptide (PP)
![Page 3: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/3.jpg)
Pancreas Gland
• Insulin : storage and anabolic hormone of the body• Islet amyloid polypeptide (IAPP, or amylin):
modulates appetite, gastric emptying, and glucagon and insulin secretion
• Glucagon: hyperglycemic factor that mobilizes glycogen stores
• Somatostatin: a universal inhibitor of secretory cells• Gastrin: stimulates gastric acid secretion• Pancreatic peptide: facilitates digestive processes by a
mechanism not yet clarified.
![Page 4: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/4.jpg)
Pancreatic Endocrine Function
• Insulin:– Promotes cell use of glucose and carbohydrate
storage (mostly in skeletal muscle)– Constantly secreted by the pancreas in response
to blood glucose levels– Stimulates glycogen synthesis in the liver– Facilitates entry of amino acids into the cell
• Incretins also stimulate insulin secretion.
![Page 5: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/5.jpg)
Pancreatic Endocrine Function
• Glucagon:– Increases circulating glucose levels– Stimulates glycogenolysis in liver, which allows
glucose to enter circulation– Also helps in converting amino acids to glucose
![Page 6: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/6.jpg)
Healthy Response
• Eat meal, peak glucose at about 30 minutes• Phase 1: stored insulin released upon
ingestion of meal• Glucose continues to rise, reaching above
100mg/dl 20 minutes later• Phase 2: beta cells secrete more insulin• 1-2 hours later, glucose levels reach around 85
mg/dl
1-6
![Page 7: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/7.jpg)
![Page 8: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/8.jpg)
Insulin promotes synthesis
![Page 9: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/9.jpg)
![Page 10: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/10.jpg)
Endocrine effects of insulin (1)
Effect on liver:
Reversal of catabolic features of insulin deficiency
Inhibits glycogenolysis
Inhibits conversion of fatty acids and amino acids to keto acids
Inhibits conversion of amino acids to glucose
Anabolic action
Promotes glucose storage as glycogen (induces glucokinase and glycogen synthase, inhibits phosphorylase)
Increases triglyceride synthesis and very-low-density lipoprotein formation
![Page 11: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/11.jpg)
Endocrine effects of insulin (2)
Effect on muscle:
Increased protein synthesis
Increases amino acid transport
Increases ribosomal protein synthesis
Increased glycogen synthesis
Increases glucose transport
Induces glycogen synthase and inhibits phosphorylase
![Page 12: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/12.jpg)
Endocrine effects of insulin (3)
Effect on adipose tissue:
Increased triglyceride storage
Lipoprotein lipase is induced and activated by insulin to hydrolyze triglycerides from lipoproteins
Glucose transport into cell provides glycerol phosphate to permit esterification of fatty acids supplied by lipoprotein transport
Intracellular lipase is inhibited by insulin
![Page 13: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/13.jpg)
Diabetes Mellitus
• Disorder of pancreatic endocrine function resulting in:– Deficient secretion of insulin– Insulin resistance
• The excess production of insulin causes the down regulation (decrease) in the number of receptors and the target cells cannot synthesize enough receptor protein to keep up, further contributing to the problem.
– Combination of both
![Page 14: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/14.jpg)
Types of DM• Type 1
– Autoimmune disorder (coxsackie virus implicates as trigger)– Destruction of beta cells– Cessation of insulin production
• Type 2– Insulin resistance– Obesity– Genetic link
• Type 3– specific causes of an elevated blood glucose
• Type 4– Gestational diabetes (GDM)
![Page 15: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/15.jpg)
Diabetes Mellitus
• Symptoms of diabetes:–Increased blood glucose levels–Glycosuria –Polyuria–Polydipsia–Polyphagia –Diabetic neuropathy
![Page 16: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/16.jpg)
Diabetes Mellitius (symptoms cont.)
• Ketoacidosis—type 1 diabetics – The breakdown of fat produces an increase in
ketone bodies in the blood. This condition is called ketosis. As the ketone level increases, metabolic acidosis (ketoacidosis) occurs.
• Amputation– Inadequate circulation to the extremities, coupled
with soft-tissue infections that resist healing, may lead to necrosis (gangrene) and the need for amputation.
1-16
![Page 17: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/17.jpg)
Diabetes Mellitus
39-17
• Blood glucose monitoring:– A healthy fasting blood glucose level is between
70 and 110mg/dL.– Glucose meters:
• Used to test blood glucose levels several times a day– Glycolated hemoglobin (HbA1c):
• Used to evaluate 3 months of glucose levels• Hemoglobin that has glucose attached to it. Because
RBCs do not require insulin to uptake glucose, glucose enters the RBC and readily binds to hemoglobin without the help of enzymes.
![Page 18: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/18.jpg)
Treatment of Diabetes Mellitus
• Immediate therapy is to correct metabolic imbalance.
• Maintenance therapy is directed at regulating blood glucose levels:– Diet control– Exercise– Medications
![Page 19: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/19.jpg)
Diabetes Treatment
• Parenteral administration:– Insulin, amylin analog, incretin mimetics
• Oral antidiabetics– Secretagogues, glucose absorption inhibitors,
biguanides, insulin sensitizers, peptidase inhibitors• *insulin and secretagogues are hypoglycemics:
decrease normal or elevated glucose levels
1-19
![Page 20: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/20.jpg)
Insulin
• Source:– Insulin was originally obtained from pork or
beef organs.
– Today it is produced only through synthesis:• Recombinant DNA technology
– Insulin available today comes in different onsets and durations of actions.
![Page 21: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/21.jpg)
Insulin preparation
• Rapid-acting• Short-acting• Intermediate-acting• Long-acting• Insulin delivery systems
![Page 22: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/22.jpg)
Extent and duration of action of various types of insulin
![Page 23: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/23.jpg)
Insulin
• Dosage:– It is usually administered 30 to 60 minutes before
meals.
– The long-acting recombinant DNA insulins are dosed once daily.
– Insulin is administered with a specifically calibrated syringe.
– Insulin pens are an alternative for delivering a precise dose.
![Page 24: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/24.jpg)
![Page 25: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/25.jpg)
Insulin
• Changes in insulin requirements:– Colds, fevers, surgery, and stress all increase glucose
levels, which increases insulin need.
– Heavy exercise can lower the insulin need.
– Drugs can affect glucose levels, requiring changes to the insulin dose.
– Allergic reactions may necessitate change to another species of insulin.
– Lipodystrophy is a disappearance of subcutaneous fat at the site of insulin injection.
![Page 26: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/26.jpg)
Insulin
• Adverse effects:– Blurred vision– Hypoglycemia– Hunger– Headache– Fatigue– Anxiety– Nervousness– Confusion– Paresthesia
![Page 27: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/27.jpg)
![Page 28: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/28.jpg)
Amylin Analogs (sc admin)
39-28
• Amylin: – It is the hormone co-secreted by the beta cells
with insulin.– Without enough amylin, blood glucose levels rise.– Slows gastric emptying and suppresses glucagon
secretion, satiety signal
• Pramlintide (Symlin):– Mimics amylin to control glucose levels– Adverse effects include vomiting, decreased
appetite, headache, and dizziness
![Page 29: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/29.jpg)
Incretin Mimetics
39-29
• Incretins: – Hormones secreted from the duodenum, due to
glucose stimulation– Increase insulin secretion
• GIP (gastric inhibitory peptide)• GLP-1 (glucagon-like peptide-1)
• Exenatide(Byetta) and liraglutide(Victoza):– Incretin mimetic– Adverse effects include nausea, diarrhea,
headache, and dizziness
![Page 30: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/30.jpg)
Oral Antidiabetic Drugs
• Used in the management of type 2 diabetes
• Approved for treatment when diet and exercise have not achieved target glycemic control
![Page 31: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/31.jpg)
Oral Antidiabetic Drugs
![Page 32: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/32.jpg)
Secretagogues
• Substances that induce or cause the secretion of another substance
• Enter beta cells and cause the release of insulin
• Do not have insulin-like activity, so should not be used in type I diabetes
![Page 33: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/33.jpg)
Secretagogues
• Sulfonylureas:– Two generations– Reduce fasting plasma glucose
• Nonsulfonylureas:– Stimulate insulin secretion– Quicker onset of action than sulfonylureas
• Both types must be taken 1 to 30 minutes before each meal.
![Page 34: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/34.jpg)
Secretagogues
• Adverse effects:– Hypoglycemia– GI irritation– Nausea– Diarrhea– Weakness– Fatigue– Dizziness
![Page 35: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/35.jpg)
Glucose Absorption Inhibitors
• Interrupt carbohydrate digestion from diet
• Glucose absorption delayed but not eliminated
• Keep blood glucose levels from peaking after meals
• Taken with each meal
![Page 36: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/36.jpg)
Glucose Absorption Inhibitors
• Adverse effects:– GI flatulence
– Diarrhea
– Abdominal pain
– Do not cause hypoglycemia unless used in combination with secretagogues or insulin
![Page 37: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/37.jpg)
Antihyperglycemic: Biguanides
• Decrease blood glucose levels after meals by decreasing liver glucose production and intestinal glucose absorption
• Enhance glucose use by other tissues in the body
• No direct effect on insulin secretion
![Page 38: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/38.jpg)
Biguanides
• Adverse effects:– Diarrhea– Nausea– Vomiting– Lactic acidosis (rare), life-threatening black box
warning
• Contraindication:– Alcohol potentiates the action of metformin on
lactic acid metabolism
![Page 39: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/39.jpg)
Insulin Sensitizers: Thiazolidinedione
• Enhance peripheral cell response to insulin
• Allow glucose to be used more efficiently
• Decrease insulin resistance and increase insulin sensitivity of fat, skeletal muscle, and liver cells
![Page 40: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/40.jpg)
Insulin Sensitizers
• Adverse effects:– Fluid retention
– Weight gain
– Headache
– Fatigue
– Diarrhea
Contraindicated liver and cardiovascular disease states.
![Page 41: Pancreatic Hormones & Antidiabetic Drugs](https://reader036.fdocuments.net/reader036/viewer/2022081412/544ca812b1af9fd54f8b4f47/html5/thumbnails/41.jpg)
Dipeptidyl Peptidase-4 Inhibitors
• DPP-4 in intestine– Breaks down GLP-1
• Inhibitor leads to:– Stimulation of insulin secretion– Decreased glucagon secretion
• Adverse effects:– Nasopharyngitis– Upper respiratory infections– Headache